Yale New Haven Hospital has reported the first cases of Pediatric Multi-System Inflammatory Syndrome
Monday, May 11, 2020
New Haven, CT (May 11, 2020) – Yale New Haven Children’s Hospital (YNHCH) has reported Connecticut’s first cases of Pediatric Multi-System Inflammatory Syndrome. YNHCH currently has three patients diagnosed with the Syndrome believed to be tied to COVID-19. The Hospital has reported all three cases to the Connecticut Department of Public Health.
“Unfortunately, this disease carries features of toxic shock syndrome and elements of Kawasaki Disease and strikes school-aged children. While these cases are exceptionally rare, given our proximity to New York where there have been a significant number reported, we have been watching their experience closely,” said Clifford Bogue, physician-in-chief of YNHCH. “We are working diligently with local and state health officials to address this issue and strongly recommend that children who may be suffering from symptoms seek early referrals to pediatric infectious disease specialists, rheumatologists or cardiologists.”
Symptoms of Pediatric Multi-System Inflammatory Syndrome include a persistent fever, rash as well as gastrointestinal symptoms such as vomiting and diarrhea. Patients can also suffer from cardiac inflammation. If your child is experiencing any of these symptoms, please call your pediatrician for advice.
Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org
New Haven, CT (August 17, 2020) – Yale New Haven Hospital and Yale School of Medicine today announced the start of Phase 3 of the Pfizer vaccine trial at the hospital. This groundbreaking study is intended to be one of several vaccine trials to be undertaken in the hopes of finding the most scientifically validated vaccine in the shortest amount of time.
New Haven, CT (August 11, 2020) – Working in direct partnership with Health System CEO Marna Borgstrom, Christopher O’Connor will become the new president of Yale New Haven Health (YNHHS) effective October 5, 2020.
New Haven, CT (July 31, 2020) – After nearly 15 years of service, Richard D’Aquila has announced his decision to transition out of his role as president of Yale New Haven Hospital and the Health System effective October 5, 2020.